Status:
COMPLETED
Safety and Efficacy of Multiple EPO Injections in Children With Cerebral Palsy
Lead Sponsor:
Bundang CHA Hospital
Conditions:
Cerebral Palsy
Brief Summary
This study is a retrospective review on the safety and efficacy of repetitive erythropoietin injection in children with cerebral palsy
Detailed Description
Cerebral palsy is mostly caused by hypoxic-ischemic encephalopathy from preterm birth, involving inflammatory and apoptotic cellular response. Erythropoietin (EPO) has shown neuroprotective effects vi...
Eligibility Criteria
Inclusion
- confirmed clinical diagnosis of cerebral palsy based on neuromotor findings,
- less than 18 years of age,
- received recombinant human erythropoietin (rhEPO) more than once.
Exclusion
- not responding to phone interview or
- no functional assessments available.
Key Trial Info
Start Date :
January 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2017
Estimated Enrollment :
164 Patients enrolled
Trial Details
Trial ID
NCT03303573
Start Date
January 1 2013
End Date
August 1 2017
Last Update
October 10 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.